Device_News

Research

The opening of a PC2 laboratory facility at SpeeDx Sydney headquarters is an exciting milestone to celebrate. SpeeDx performs all commercial functions including research, development and manufacturing out of their...

  A prospective evaluation study published in the Journal of Clinical Microbiology evaluated our ResistancePlus® MG assay against 1089 symptomatic and asymptomatic male and female urine and anogenital swab samples. Key Findings 6%...